CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ±è¹Ì°æ
  • ¼Ò ¼Ó: °­³²Â÷º´¿ø
  • Àü¹®ºÐ¾ß : ºñÁ¤»óÀڱðæºÎ¼¼Æ÷Áø, º¹°­°æ, ÀڱñÙÁ¾, ³­¼ÒÁ¾¾ç, Àڱ󻸷Áõ, Àڱü±±ÙÁõ, Àڱðæ, ´ÜÀÏ°ø ¼ö¼ú
  • Á÷ À§: ºñ°ø°³
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 02.3468.3000
  • ÆÑ ½º: 02.558.1119
  • ÁÖ ¼Ò: ¼­¿ï½Ã °­³²±¸ ¿ª»ï1µ¿ 650-9 ¿ì)135-913
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
160 (±¹³»)KCI Prediction of pregnancy complication occurrence using fetal cardiac output assessments made by ultrasonography at 20 to 24 weeks of gestation
159 (±¹¿Ü)SCI The Delta Neutrophil Index as a predictive marker of histological chorioamnionitis in patients with preterm premature rupture of membranes: A retrospective study
158 (±¹¿Ü)SCI Increased delta neutrophil index in women with severe preeclampsia
157 (±¹³»)SCI Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin ratio in patients with type 2 diabetes mellitus.
156 (±¹³»)KCI An overview of current knowledge about cell-free RNA in amniotic fluid
155 (±¹³»)KCI Myotonic dystrophy diagnosed during the perinatal period: A case series
154 (±¹¿Ü)SCI A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system(total content 13.5mg), in an Asia-Pacific population
153 (±¹³»)KCI Serum from pregnant women with gestational diabetes mellitus increases the expression of FABP4 mRNA in primary subcutaneous human pre-adipocytes
152 (±¹¿Ü)SCI The U-shaped relationship between fibroblast growth factor 21 and microvascular complication in type 2 diabetes mellitus.
151 (±¹¿Ü)SCI Immune-modulatory effect of CD200-positive human placenta-derived stem cells in the early phase of stroke
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 13 14 15 16 17 18 19 20 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729